BioNTech SE (BNTX) is destined for greater heights as its last quarter sales were 3,486 M

A new trading day began on January 24, 2023, with BioNTech SE (NASDAQ: BNTX) stock priced at $143.28, up 0.08% from the previous day of trading. During the day, the shares moved up to $144.37 and dropped to $140.70 before settling in for the closing price of $143.73. BNTX’s price has ranged from $117.08 to $188.99 over the past 52 weeks.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…


Meanwhile, its annual earnings per share averaged -7.20%. With a float of $215.11 million, this company’s outstanding shares have now reached $240.23 million.

Let’s look at the performance matrix of the company that is accounted for 3082 employees. In terms of profitability, gross margin is +99.49, operating margin of +92.93, and the pretax margin is +79.29.

BioNTech SE (BNTX) Insider Updates

As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of BioNTech SE is 62.96%, while institutional ownership is 17.00%.

BioNTech SE (BNTX) Performance Highlights and Predictions

In its latest quarterly report, released on 6/29/2022, the company reported earnings of $6.26 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). This company achieved a net margin of +54.24 while generating a return on equity of 160.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of 7.79 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around -7.20% per share during the next fiscal year.

BioNTech SE (NASDAQ: BNTX) Trading Performance Indicators

Here are BioNTech SE’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 5.30. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.70. Likewise, its price to free cash flow for the trailing twelve months is 2.57.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 44.18, a number that is poised to hit 8.54 in the next quarter and is forecasted to reach 17.86 in one year’s time.

Technical Analysis of BioNTech SE (BNTX)

BioNTech SE (NASDAQ: BNTX) saw its 5-day average volume 0.82 million, a negative change from its year-to-date volume of 0.84 million. As of the previous 9 days, the stock’s Stochastic %D was 29.19%. Additionally, its Average True Range was 6.09.

During the past 100 days, BioNTech SE’s (BNTX) raw stochastic average was set at 36.14%, which indicates a significant increase from 27.87% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 29.84% in the past 14 days, which was lower than the 50.89% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $159.95, while its 200-day Moving Average is $152.16. Nevertheless, the first resistance level for the watch stands at $145.25 in the near term. At $146.64, the stock is likely to face the second major resistance level. The third major resistance level sits at $148.92. If the price goes on to break the first support level at $141.58, it is likely to go to the next support level at $139.30. Assuming the price breaks the second support level, the third support level stands at $137.91.

BioNTech SE (NASDAQ: BNTX) Key Stats

With a market capitalization of 34.21 billion, the company has a total of 242,685K Shares Outstanding. Currently, annual sales are 22,451 M while annual income is 12,177 M. The company’s previous quarter sales were 3,486 M while its latest quarter income was 1,798 M.


On What Basis Did Swvl Holdings Corp (SWVL) Stock Rise 47% Pre-Hours?

When last checked, Swvl Holdings Corp. (Nasdaq: SWVL), a...

What Drove Organovo (ONVO) Stock Up 15% In After-Hour Session On Tuesday?

Shares of Organovo Holdings Inc. (Nasdaq: ONVO) were up...

Is There Any Reason As To Why The Zai Lab (ZLAB) Stock Expanded By 13%?

The biopharmaceutical business Zai Lab Limited (NASDAQ: ZLAB), which...



Don't miss

Wearable Devices (WLDS) Stock Rose 12% On Tuesday, But On What Basis?

Wearable Devices Ltd (NASD: WLDS) is experiencing significant growth...

Did Anything Boost ObsEva (OBSV) Stock In Pre-Hours Trading?

Following an update, shares of ObsEva SA (NASD: OBSV)...

How Did The Kalera (KAL) Stock Rise 32% Pre-Hours?

At the time of the most recent check, shares...

Why Has Selina Hospitality (SLNA) Stock Increased In Extended Session On Friday?

The stock of Selina Hospitality PLC (NASD: SLNA), which...

Do You Know Why Evolv Technologies (EVLV) Stock Surged Nearly 10% Today?

Today's charts show Evolv Technologies Holdings Inc. (Nasdaq: EVLV)...

Focus Financial Partners Inc. (FOCS) is set for another landmark as it hit the volume of 5.36 million

Focus Financial Partners Inc. (NASDAQ: FOCS) open the trading on February 02, 2023, with great promise as it jumped 8.08% to $50.01. During the...

3D Systems Corporation (DDD) last month performance of 65.42% certainly makes it a sizzling prospect

Witnessing the stock’s movement on the chart, on February 02, 2023, 3D Systems Corporation (NYSE: DDD) set off with pace as it heaved 12.53%...

The key reasons why UP Fintech Holding Limited (TIGR) is -37.06% away from 52-week high?

UP Fintech Holding Limited (NASDAQ: TIGR) established initial surge of 3.25% at $4.45, as the Stock market unbolted on February 02, 2023. During the...


Please enter your comment!
Please enter your name here